Nanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention

Hadil Faris Alotaibi, Stefano Perni, Polina Prokopovich School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UKCorrespondence: Polina ProkopovichSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, UKT...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alotaibi HF, Perni S, Prokopovich P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/228f22f1fe384b84807cdc394a792c5e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:228f22f1fe384b84807cdc394a792c5e
record_format dspace
spelling oai:doaj.org-article:228f22f1fe384b84807cdc394a792c5e2021-12-02T08:22:01ZNanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention1178-2013https://doaj.org/article/228f22f1fe384b84807cdc394a792c5e2019-09-01T00:00:00Zhttps://www.dovepress.com/nanoparticle-based-model-of-anti-inflammatory-drug-releasing-lbl-coati-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Hadil Faris Alotaibi, Stefano Perni, Polina Prokopovich School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UKCorrespondence: Polina ProkopovichSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, UKTel +44 29 208 75820Fax +44 29 208 74149Email prokopovichp@cardiff.ac.ukIntroduction: The only treatment for aseptic loosening is the replacement of the prosthesis through revision surgery. A preventive approach, achieved through anti-inflammatory drugs released from the device, has shown to be a viable strategy; however, the performance of these devices is not yet satisfactory thus further improvements are necessary.Methods: We used titanium nanoparticles as a model for implant surfaces and developed a coating containing dexamethasone (DEX) using layer-by-layer deposition.Results: The amount of deposited drug depended on the number of layers and the release was sustained for months. The efficiency of the released DEX in reducing inflammation markers (tumor necrosis factor alpha and IL-6) produced by human monocytes and macrophages was similar to the pure drug at the same concentration without negative impacts on the viability and morphology of these cells.Conclusion: These coatings were not inferior to medical grade titanium (the standard material used in uncemented devices) regarding their ability to sustain osteoblasts and fibroblasts growth.Keywords: titanium, cementless prosthesis, aseptic loosening, dexamethasoneAlotaibi HFPerni SProkopovich PDove Medical Pressarticletitaniumcementless prosthesisaseptic looseningdexamethasoneMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 7309-7322 (2019)
institution DOAJ
collection DOAJ
language EN
topic titanium
cementless prosthesis
aseptic loosening
dexamethasone
Medicine (General)
R5-920
spellingShingle titanium
cementless prosthesis
aseptic loosening
dexamethasone
Medicine (General)
R5-920
Alotaibi HF
Perni S
Prokopovich P
Nanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention
description Hadil Faris Alotaibi, Stefano Perni, Polina Prokopovich School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UKCorrespondence: Polina ProkopovichSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff CF10 3NB, UKTel +44 29 208 75820Fax +44 29 208 74149Email prokopovichp@cardiff.ac.ukIntroduction: The only treatment for aseptic loosening is the replacement of the prosthesis through revision surgery. A preventive approach, achieved through anti-inflammatory drugs released from the device, has shown to be a viable strategy; however, the performance of these devices is not yet satisfactory thus further improvements are necessary.Methods: We used titanium nanoparticles as a model for implant surfaces and developed a coating containing dexamethasone (DEX) using layer-by-layer deposition.Results: The amount of deposited drug depended on the number of layers and the release was sustained for months. The efficiency of the released DEX in reducing inflammation markers (tumor necrosis factor alpha and IL-6) produced by human monocytes and macrophages was similar to the pure drug at the same concentration without negative impacts on the viability and morphology of these cells.Conclusion: These coatings were not inferior to medical grade titanium (the standard material used in uncemented devices) regarding their ability to sustain osteoblasts and fibroblasts growth.Keywords: titanium, cementless prosthesis, aseptic loosening, dexamethasone
format article
author Alotaibi HF
Perni S
Prokopovich P
author_facet Alotaibi HF
Perni S
Prokopovich P
author_sort Alotaibi HF
title Nanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention
title_short Nanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention
title_full Nanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention
title_fullStr Nanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention
title_full_unstemmed Nanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention
title_sort nanoparticle-based model of anti-inflammatory drug releasing lbl coatings for uncemented prosthesis aseptic loosening prevention
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/228f22f1fe384b84807cdc394a792c5e
work_keys_str_mv AT alotaibihf nanoparticlebasedmodelofantiinflammatorydrugreleasinglblcoatingsforuncementedprosthesisasepticlooseningprevention
AT pernis nanoparticlebasedmodelofantiinflammatorydrugreleasinglblcoatingsforuncementedprosthesisasepticlooseningprevention
AT prokopovichp nanoparticlebasedmodelofantiinflammatorydrugreleasinglblcoatingsforuncementedprosthesisasepticlooseningprevention
_version_ 1718398533338398720